Cell-Permeable PKCβII Peptide Inhibition Reduced Cell Viability in MCF-7 Breast Cancer Cells: Implications for ER+ Breast Cancer Treatment

Authors

• Sindy Hernandez

Publication/Presentation Date

5-2026

Volume

147

Issue

5

First Page

4

Last Page

4

Published In/Presented At

Chen, Q., Melnik, J. M., Hernandez, S. P., & Young, L. (2026). Cell-Permeable PKCβII Peptide Inhibition Reduced Cell Viability in MCF-7 Breast Cancer Cells: Implications for ER+ Breast Cancer Treatment [ID 3627]. Obstetrics & Gynecology, 147(5S), 4S-4S. https://doi.org/10.1097/AOG.0000000000006265.02

Disciplines

Medicine and Health Sciences

Department(s)

Medical Education

Document Type

Article